Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. RNA counts overall and by race and estrogen receptor (ER) status from CBCS Phase 3, 2008–2013. Table S3. Gene expression and risk of recurrence among women with ER+/HER2– breast cancer from CBCS Phase 3, 2008–2013. (DOCX 81 kb
Table S1. SVM BRCA1-like status and BRCA1ness-MLPA profiles in 10 breast cancer cell lines. Table S2...
Table S1. Clinicopathological characteristics of BC patient samples. Table S2. The expression of AFF...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...
Table S1. Clinical data of TCGA patients. The data was updated with the available follow up informat...
Table S1. Differential expression of BRK mRNA in various cancers. Table S2. BRK mRNA expression in a...
Table S1. List of 585 candidate genes. Table S2. List and identifiers for the 747-patient microarray...
Stratified gene expression analysis comparing estrogen-receptor-positive (ER+) premenopausal (preM) ...
Classification of luminal breast cancer cases using data from medical records in the AMBER consortiu...
Genes and probe sets used to characterize subgroups within ERâ/PgR+/HER2â phenotype. (DOC 40 kb
The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (MET...
Table S1. Variant annotation for good outcome-associated ERBS in ER ChIP-seq samples with good outco...
Figure S1-S17. Genome U plots of all the additional cases. Figure S18 Heat map of the EGFR and ERBB3...
Table S2. Genes found to be differentially expressed in multiple studies included in scenario 1 (inv...
Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...
Table S1. SVM BRCA1-like status and BRCA1ness-MLPA profiles in 10 breast cancer cell lines. Table S2...
Table S1. Clinicopathological characteristics of BC patient samples. Table S2. The expression of AFF...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...
Table S1. Clinical data of TCGA patients. The data was updated with the available follow up informat...
Table S1. Differential expression of BRK mRNA in various cancers. Table S2. BRK mRNA expression in a...
Table S1. List of 585 candidate genes. Table S2. List and identifiers for the 747-patient microarray...
Stratified gene expression analysis comparing estrogen-receptor-positive (ER+) premenopausal (preM) ...
Classification of luminal breast cancer cases using data from medical records in the AMBER consortiu...
Genes and probe sets used to characterize subgroups within ERâ/PgR+/HER2â phenotype. (DOC 40 kb
The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (MET...
Table S1. Variant annotation for good outcome-associated ERBS in ER ChIP-seq samples with good outco...
Figure S1-S17. Genome U plots of all the additional cases. Figure S18 Heat map of the EGFR and ERBB3...
Table S2. Genes found to be differentially expressed in multiple studies included in scenario 1 (inv...
Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...
Table S1. SVM BRCA1-like status and BRCA1ness-MLPA profiles in 10 breast cancer cell lines. Table S2...
Table S1. Clinicopathological characteristics of BC patient samples. Table S2. The expression of AFF...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...